ID 238725705 · FY 2021–2024 · 4 years
Subsidiary of შპს სამედიცინო საინვესტიციო ჯგუფი (100.0%)
| Line item | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|
| Total Revenue | 6,475 | 2,750 | 1,500 | 1,411 | -39.8% |
| Total COGS | -3,678 | -1,291 | -622 | -656 | -43.7% |
| Gross Profit | 2,797 | 1,459 | 877 | 755 | -35.4% |
| Gross Margin | 43.2% | 53.0% | 58.5% | 53.5% | |
| Total Operating Expenses | -2,323 | -1,413 | -1,282 | -1,183 | -20.1% |
| EBITDA | 474 | 46 | -405 | -428 | nmf |
| EBITDA Margin | 7.3% | 1.7% | -27.0% | -30.3% | |
| Total D&A | -453 | -579 | -641 | -659 | +13.3% |
| EBIT / Operating Income | 21 | -532 | -1,046 | -1,087 | nmf |
| Total Other Income | 0 | -237 | -172 | -65 | -47.8% |
| Profit Before Tax | 21 | -770 | -1,217 | -1,152 | nmf |
| Total Income Tax | 0 | -1 | 0 | 0 | |
| Net Profit / (Loss) | 474 | -192 | -576 | -493 | nmf |
| Net Margin | 7.3% | -7.0% | -38.4% | -34.9% |
Ownership & directors from companyinfo.ge (public corporate registry).